225 related articles for article (PubMed ID: 23379971)
1. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.
Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
Diagn Pathol; 2013 Feb; 8():17. PubMed ID: 23379971
[TBL] [Abstract][Full Text] [Related]
2. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
3. Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.
Stålhammar G; Farrajota P; Olsson A; Silva C; Hartman J; Elmberger G
Ann Diagn Pathol; 2015 Aug; 19(4):203-10. PubMed ID: 25921313
[TBL] [Abstract][Full Text] [Related]
4. Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH.
Yoon N; Do IG; Cho EY
APMIS; 2014 Sep; 122(9):755-60. PubMed ID: 24372629
[TBL] [Abstract][Full Text] [Related]
5. Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas.
Tafe LJ; Allen SF; Steinmetz HB; Dokus BA; Cook LJ; Marotti JD; Tsongalis GJ
Exp Mol Pathol; 2014 Aug; 97(1):116-9. PubMed ID: 24927872
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system.
Stevens R; Almanaseer I; Gonzalez M; Caglar D; Knudson RA; Ketterling RP; Schrock DS; Seemayer TA; Bridge JA
J Mol Diagn; 2007 Apr; 9(2):144-50. PubMed ID: 17384205
[TBL] [Abstract][Full Text] [Related]
7. Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer.
Nishimura R; Kagawa A; Tamogami S; Kojima K; Satou M; Yamashita N; Teramoto N; Aogi K
Breast Cancer; 2016 Mar; 23(2):211-5. PubMed ID: 25033760
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of HER2 status in breast carcinoma using fully automated HER2 staining and fluorescence in-situ hybridization technology].
Ying JM; Liu XY; Guo L; Xie YQ; Lü N
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):296-300. PubMed ID: 22883666
[TBL] [Abstract][Full Text] [Related]
9. Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues.
Zakrzewski F; de Back W; Weigert M; Wenke T; Zeugner S; Mantey R; Sperling C; Friedrich K; Roeder I; Aust D; Baretton G; Hönscheid P
Sci Rep; 2019 Jun; 9(1):8231. PubMed ID: 31160649
[TBL] [Abstract][Full Text] [Related]
10. Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study.
van der Logt EM; Kuperus DA; van Setten JW; van den Heuvel MC; Boers JE; Schuuring E; Kibbelaar RE
PLoS One; 2015; 10(4):e0123201. PubMed ID: 25844540
[TBL] [Abstract][Full Text] [Related]
11. Utility of cytopathological specimens and an automated image analysis for the evaluation of HER2 status and intratumor heterogeneity in breast carcinoma.
Arihiro K; Oda M; Ogawa K; Kaneko Y; Shimizu T; Tanaka Y; Marubashi Y; Ishida K; Takai C; Taoka C; Kimura S; Shiroma N
Pathol Res Pract; 2016 Dec; 212(12):1126-1132. PubMed ID: 27712974
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
[TBL] [Abstract][Full Text] [Related]
13. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
[TBL] [Abstract][Full Text] [Related]
15. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
17. Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH).
Fritzsche FR; Bode PK; Moch H; Kristiansen G; Varga Z; Bode B
Am J Surg Pathol; 2010 Aug; 34(8):1180-5. PubMed ID: 20661016
[TBL] [Abstract][Full Text] [Related]
18. Concordance of HER2 Immunohistochemistry and Fluorescence
Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
Anticancer Res; 2017 Jun; 37(6):3323-3329. PubMed ID: 28551685
[TBL] [Abstract][Full Text] [Related]
19. Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.
Radziuviene G; Rasmusson A; Augulis R; Lesciute-Krilaviciene D; Laurinaviciene A; Clim E; Laurinavicius A
Biomed Res Int; 2017; 2017():2321916. PubMed ID: 28752092
[TBL] [Abstract][Full Text] [Related]
20. Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.
Ercolani C; Marchiò C; Di Benedetto A; Fabi A; Perracchio L; Vici P; Sperati F; Buglioni S; Arena V; Pescarmona E; Sapino A; Terrenato I; Mottolese M
J Exp Clin Cancer Res; 2017 Oct; 36(1):143. PubMed ID: 29029640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]